Bixiye
QP8-21 Change in Suspect COVID-19 Diagnosis Code
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1831 - 1840 ee natiijooyinka 3613
Bixiye
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
QP3-21 Commercial and MHCP Pharmacy Benefit Exclusion for Barhemsys® and Monoferric®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
QP123-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2020
Bixiye
P81R1-20 Update: eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Jan 04, 2021
Bixiye
P5-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Taariikhda uu dhaqangalayo Barnaamijka: Jan 04, 2021